Brought to you by 
Shionogi acquires all of Victory Pharma’s marketed products for $118mm
18 Nov 2022
Executive Summary
Shionogi & Co. Ltd.’s US division Shionogi Inc. has paid $118mm in cash to purchase all of specialty pharmaceutical company Victory Pharma Inc.’s marketed products--seven pain medications and two antibiotics. All of the drugs are approved by the FDA.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Shionogi acquires all of Victory Pharma’s marketed products for $118mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice